CalciMedica is trading at $1.55, down 5.48%, as its earlier premarket gain has reversed.

  • A November 2 premarket report said the stock had risen after its 16.57% decline on October 30, but identified no company-specific catalyst.
  • Its investor-relations page lists no November 2 announcement; its latest release is dated September 8.
  • Major indices are higher, unlike the stock, so broad-market strength does not explain its decline.